IDT Biologika GmbH
NDC Database

IDT Biologika GmbH

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing
  • Total Records 2
  • Latest Marketing Date 2022-02-01
  • Data Source FDA
  • First Marketing Date 2022-02-01
Company Overview

Company

IDT Biologika GmbH

Country

Germany

Website

Visit Website

Email

sandra.mueller@idt-biologika.de

Social Profiles

LinkedIn X / Twitter
Company Snapshot

IDT Biologika GmbH

Am Pharmapark, 06861 Dessau-Rosslau

Germany

idt-biologika.com/ sandra.mueller@idt-biologika.de View on Map
NDC Records ( 2 records )
2022
01 Feb
Drug for Further Processing NDC: 60152-002

Nonproprietary Name

talimogene laherparepvec

Dosage Form

INJECTION, SUSPENSION

Strength

1000000 [PFU]/mL

Labeler

IDT Biologika GmbH

Marketing Category

DRUG FOR FURTHER PROCESSING

60152-002

Substance

TALIMOGENE LAHERPAREPVEC

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-02-01

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2022
01 Feb
Drug for Further Processing NDC: 60152-003

Nonproprietary Name

talimogene laherparepvec

Dosage Form

INJECTION, SUSPENSION

Strength

100000000 [PFU]/mL

Labeler

IDT Biologika GmbH

Marketing Category

DRUG FOR FURTHER PROCESSING

60152-003

Substance

TALIMOGENE LAHERPAREPVEC

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-02-01

End Marketing Date

-

Listing Record Certified Through

2027-12-31

Related Databases
  • FDA Inspections
    6 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    2 View
  • FDA Approved Drugs Database
    0 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
2 total
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

60152-002

Nonproprietary Name

talimogene laherparepvec

Labeler

IDT Biologika GmbH

Dosage Form

INJECTION, SUSPENSION

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit